Trials / Sponsors / Genome & Company
Genome & Company
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-02-01 |
| Terminated | GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer Biliary Tract Cancer | Phase 2 | 2023-09-18 |
| Completed | GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2022-04-07 |
| Completed | GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have P Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck | Phase 1 | 2020-10-26 |